Oral nanozyme treats colitis-linked mental disorders via gut-brain axis
| Date | 19th, Feb 2026 |
|---|---|
| Source | Nanowerk - Nanotechnology Websites |
DESCRIPTION
Oral polysaccharide-engineered nanozyme treats colitis-linked mental disorders by targeting oxidative stress and gut dysbiosis via the microbiome-gut-brain axis.